TRAVIS BOSS: Open Payments
NPI 1538904297 · MILLERSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 67 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $1,585
Food & beverage: $1,585
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $438 |
| PFIZER INC. | 14 | $300 |
| AstraZeneca Pharmaceuticals LP | 4 | $199 |
| Lilly USA, LLC | 9 | $163 |
| Corcept Therapeutics | 5 | $122 |
| Exact Sciences Corporation | 3 | $69 |
| ABBVIE INC. | 2 | $53 |
| Amgen Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, NURTEC ODT, Rybelsus, Korlym, ELIQUIS, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
